ロード中...
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
Atherosclerosis (AS), especially atherosclerotic cardiovascular diseases (ASCVDs), and metabolic diseases (such as diabetes, obesity, dyslipidemia, and nonalcoholic fatty liver disease) are major public health issues worldwide that seriously threaten human health. Exploring effective natural product...
保存先:
| 出版年: | Front Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8299362/ https://ncbi.nlm.nih.gov/pubmed/34305616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.709629 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|